Panacea Biotec was set up in the year 1984, under the name of Panacea Drugs Private Limited and was publicly listed in the year 1995. Panacea Biotec is a research based Biotechnology company doing Research and Development, Manufacturing, Sales, Distribution and Marketing of Pharmaceuticals, Vaccines and Biosimilars.
Financial Results:
- Panacea Biotec Ltd. reported Total Income for Q4FY23 of ₹ 144 Crores up from ₹ 145 Crore year on year, a fall of 0.54%.
- Total Expenses for Q4FY23 of ₹ 145 Crores up from ₹ 213 Crores year on year, fall of 32%.
- Consolidated Net Profit of ₹ (13) Crores, down from ₹ 1,237 Crores in the same quarter of the previous year.
- The Earnings per Share is ₹ (2.07), up 61% from ₹ 202.03 in the same quarter of the previous year.